Acadia Healthcare Company, Inc. (ACHC)
USD 24.22
(1.57%)
USD 24.22
(1.57%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 176.01 Million USD | -72.88% |
| 2022 | 649.07 Million USD | 14.8% |
| 2021 | 565.41 Million USD | 9.71% |
| 2020 | 515.37 Million USD | -40.26% |
| 2019 | 862.68 Million USD | 5.07% |
| 2018 | 821.03 Million USD | 9.79% |
| 2017 | 747.83 Million USD | 5.85% |
| 2016 | 706.49 Million USD | 68.5% |
| 2015 | 419.28 Million USD | 101.58% |
| 2014 | 208 Million USD | 43.57% |
| 2013 | 144.88 Million USD | 86.67% |
| 2012 | 77.61 Million USD | -5.92% |
| 2011 | 82.5 Million USD | 654.87% |
| 2010 | 10.92 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 638.81 Million USD | 0.93% |
| 2024 Q1 | 45.68 Million USD | 0.31% |
| 2024 Q2 | 48.05 Million USD | 5.17% |
| 2023 Q3 | 584.41 Million USD | 218.57% |
| 2023 Q4 | 45.54 Million USD | -92.21% |
| 2023 Q2 | 183.45 Million USD | 4.86% |
| 2023 FY | 176.01 Million USD | -72.88% |
| 2023 Q1 | 174.95 Million USD | 2.44% |
| 2022 Q3 | 162.61 Million USD | 3.48% |
| 2022 Q1 | 158.51 Million USD | 18.12% |
| 2022 Q4 | 170.79 Million USD | 5.03% |
| 2022 FY | 649.07 Million USD | 14.8% |
| 2022 Q2 | 157.14 Million USD | -0.86% |
| 2021 Q2 | 143.71 Million USD | 4.19% |
| 2021 Q4 | 134.19 Million USD | -10.28% |
| 2021 Q3 | 149.56 Million USD | 4.07% |
| 2021 Q1 | 137.93 Million USD | 11.64% |
| 2021 FY | 565.41 Million USD | 9.71% |
| 2020 Q1 | 224.33 Million USD | 1.76% |
| 2020 FY | 515.37 Million USD | -40.26% |
| 2020 Q2 | 213.48 Million USD | -4.84% |
| 2020 Q3 | 222.54 Million USD | 4.24% |
| 2020 Q4 | 123.55 Million USD | -44.48% |
| 2019 FY | 862.68 Million USD | 5.07% |
| 2019 Q2 | 214.6 Million USD | 1.34% |
| 2019 Q3 | 215.88 Million USD | 0.6% |
| 2019 Q4 | 220.44 Million USD | 2.12% |
| 2019 Q1 | 211.75 Million USD | 1.65% |
| 2018 FY | 821.03 Million USD | 9.79% |
| 2018 Q4 | 208.32 Million USD | -0.56% |
| 2018 Q3 | 209.49 Million USD | 4.28% |
| 2018 Q2 | 200.9 Million USD | -0.69% |
| 2018 Q1 | 202.31 Million USD | 4.72% |
| 2017 Q4 | 193.19 Million USD | 1.22% |
| 2017 Q1 | 179.7 Million USD | -0.94% |
| 2017 FY | 747.83 Million USD | 5.85% |
| 2017 Q2 | 184.07 Million USD | 2.43% |
| 2017 Q3 | 190.86 Million USD | 3.68% |
| 2016 FY | 706.49 Million USD | 68.5% |
| 2016 Q3 | 183.59 Million USD | -2.59% |
| 2016 Q1 | 153.01 Million USD | 27.93% |
| 2016 Q2 | 188.46 Million USD | 23.17% |
| 2016 Q4 | 181.41 Million USD | -1.19% |
| 2015 FY | 419.28 Million USD | 101.58% |
| 2015 Q4 | 119.61 Million USD | 5.45% |
| 2015 Q3 | 113.43 Million USD | 8.76% |
| 2015 Q2 | 104.29 Million USD | 27.27% |
| 2015 Q1 | 81.94 Million USD | 31.96% |
| 2014 Q4 | 62.09 Million USD | 3.76% |
| 2014 Q2 | 44.36 Million USD | 6.39% |
| 2014 Q3 | 59.84 Million USD | 34.91% |
| 2014 Q1 | 41.69 Million USD | 8.19% |
| 2014 FY | 208 Million USD | 43.57% |
| 2013 Q4 | 38.53 Million USD | 0.44% |
| 2013 Q1 | 31.94 Million USD | 46.87% |
| 2013 Q2 | 36.02 Million USD | 12.77% |
| 2013 FY | 144.88 Million USD | 86.67% |
| 2013 Q3 | 38.37 Million USD | 6.51% |
| 2012 Q2 | 78.16 Million USD | 4.89% |
| 2012 Q3 | 20.65 Million USD | -73.58% |
| 2012 Q1 | 74.52 Million USD | 68.6% |
| 2012 Q4 | 21.75 Million USD | 5.32% |
| 2012 FY | 77.61 Million USD | -5.92% |
| 2011 Q4 | 44.2 Million USD | 230.22% |
| 2011 Q2 | 18.19 Million USD | 12.17% |
| 2011 FY | 82.5 Million USD | 654.87% |
| 2011 Q1 | 16.21 Million USD | 1378.4% |
| 2011 Q3 | 13.38 Million USD | -26.41% |
| 2010 Q4 | 1.09 Million USD | -67.61% |
| 2010 Q3 | 3.38 Million USD | 0.0% |
| 2010 FY | 10.92 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Addus HomeCare Corporation | 248.92 Million USD | 29.289% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | -48.758% |
| Amedisys, Inc. | 834.47 Million USD | 78.907% |
| American Oncology Network, Inc. | 83.97 Million USD | -109.602% |
| Astrana Health, Inc. | 112.59 Million USD | -56.321% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 70.033% |
| IMAC Holdings, Inc. | 5.02 Million USD | -3401.265% |
| biote Corp. | 98.82 Million USD | -78.104% |
| Cryo-Cell International, Inc. | 35.2 Million USD | -399.96% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 47.878% |
| COMPASS Pathways plc | 136.91 Million USD | -28.553% |
| DocGo Inc. | 180.32 Million USD | 2.393% |
| The Ensign Group, Inc. | 335.39 Million USD | 47.52% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 6.917% |
| InnovAge Holding Corp. | 558.25 Million USD | 68.471% |
| Assure Holdings Corp. | 15.43 Million USD | -1040.054% |
| The Joint Corp. | 109.22 Million USD | -61.15% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 64.169% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | -864.872% |
| ModivCare Inc. | 586.89 Million USD | 70.01% |
| NewGenIvf Group Limited | 1.63 Million USD | -10635.492% |
| Novo Integrated Sciences, Inc. | 13.5 Million USD | -1203.233% |
| Option Care Health, Inc. | 666.62 Million USD | 73.597% |
| P3 Health Partners Inc. | 199.56 Million USD | 11.802% |
| P3 Health Partners Inc. | 199.56 Million USD | 11.802% |
| The Pennant Group, Inc. | 88.99 Million USD | -97.779% |
| Surgery Partners, Inc. | 319.5 Million USD | 44.91% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -3993.803% |
| Talkspace, Inc. | 97.58 Million USD | -80.362% |
| Talkspace, Inc. | 97.58 Million USD | -80.362% |
| The Oncology Institute, Inc. | 136.59 Million USD | -28.861% |
| The Oncology Institute, Inc. | 136.59 Million USD | -28.861% |